| Atlantic International Reports Fourth Quarter and Full Year 2025 Results |
Globe Newswire |
04/16 |
08:00 |
| Diginex Limited (DGNX) Announces US$1.5 Billion AI Acquisition, Adding High Growth Business and Targets $280M Revenue by 2027 |
Globe Newswire |
04/16 |
08:00 |
| BIO-key Expects 50% Increase in First Half Revenues, Driving Profitability in the Period |
Globe Newswire |
04/16 |
07:59 |
| Edison Initiates Coverage on One and One Green Technologies with a US$8.3 Base Case Valuation |
Globe Newswire |
04/16 |
07:45 |
| Duncan-Parnell Joins GeoCue Global Distribution Network to Expand Access to TrueView LiDAR and LP360 Software Across the Southeast |
Globe Newswire |
04/16 |
07:43 |
| Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors |
Globe Newswire |
04/16 |
07:30 |
| Helus Pharma Strengthens Medical Leadership by Appointing Dr. Ken Kramer as Senior Vice President, Medical Affairs |
Globe Newswire |
04/16 |
07:30 |
| EDAP to Announce First Quarter 2026 Financial Results on May 7, 2026 |
Globe Newswire |
04/16 |
07:30 |
| Ealixir Reports Full Year 2025 Results |
Globe Newswire |
04/16 |
07:30 |
| Paratek Pharmaceuticals to Present New Data on NUZYRA® (omadacycline) at ESCMID Global 2026 |
Globe Newswire |
04/16 |
07:30 |
| SAGA Metals Executes Title Transfer Agreement to Expand Wolverine Heavy Rare Earth Element Project in Labrador—Grab Sample Assays Included up to 21.6% TREO |
Globe Newswire |
04/16 |
07:30 |
| Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences |
Globe Newswire |
04/16 |
07:30 |
| JD.com Files Its Annual Report on Form 20-F |
Globe Newswire |
04/16 |
07:30 |
| Kane Biotech Presents revyve® Clinical Data at Symposium on Advanced Wound Care (SAWC) Spring Conference |
Globe Newswire |
04/16 |
07:25 |
| Alterity Therapeutics Announces Late-Breaker Oral Presentation at the American Academy of Neurology Annual Meeting |
Globe Newswire |
04/16 |
07:25 |
| MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP) |
Globe Newswire |
04/16 |
07:10 |
| Abaxx to Launch World’s First Exchange-Traded Solar Futures Contract |
Globe Newswire |
04/16 |
07:00 |
| Eshallgo Announces 1 for 16 Share Consolidation |
Globe Newswire |
04/16 |
07:00 |
| Redefining Enterprise Engagement at InnoEX Hong Kong: Aurora Mobile's EngageLab Unveils AI-First Solutions |
Globe Newswire |
04/16 |
07:00 |
| Marvel Biosciences Identifies Liquid Formulations for Neurodevelopmental Disorders |
Globe Newswire |
04/16 |
07:00 |
| Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency |
Globe Newswire |
04/16 |
07:00 |
| CareCloud Reaffirms Guidance Following Capital Structure Simplification, Capping a Decade of Transformation |
Globe Newswire |
04/16 |
07:00 |
| Why Human-in-the-Loop Quality and Simulation-Ready Data Assets Are Non-Negotiable for Safety-Critical AI |
Globe Newswire |
04/16 |
07:00 |
| Nula Therapeutics Launches with up to $20 Million ARPA-H Award to Advance a New Class of Medicines Targeting the Nuclear Envelope of Cells |
Globe Newswire |
04/16 |
07:00 |
| MeiraGTx Announces Positive Three-year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Late Radiation-Induced Xerostomia |
Globe Newswire |
04/16 |
07:00 |
